| URL | https://investors.tcr2.com/news-releases/news-rele |
| Source | TCR2 Therapeutics |
| Date Published | 11/01/2021 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | TCR2 Therapeutics Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| Domestically, the work will be done: | In-house |
| City reshored to: | Rockville |
| State(s) reshored to: | MD |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | cancer treatments |